1 / 25

Introduction to Healthcare and Public Health in the US

Introduction to Healthcare and Public Health in the US. Meaningful Use of Health Information Technology. Lecture b.

randalj
Download Presentation

Introduction to Healthcare and Public Health in the US

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b This material (Comp1_Unit10b) was developed by [University Name], funded by the Department of Health and Human Services, Office of the National Coordinator for Health Information Technology under Award Number [enter the award number(s)].

  2. Meaningful Use (MU) of Health Information TechnologyLearning Objectives • Define meaningful use (MU) of health information technology in the context of the Health Information Technology for Economic and Clinical Health (HITECH) Act (Lecture a) • Describe the major goals of meaningful use (Lecture a) • Define the criteria for Stage 1 of meaningful use for eligible professionals and eligible hospitals (Lecture b) • Describe the standards specified for Stage 1 of meaningful use, including those devoted to privacy and security (Lecture b) • Discuss the likely criteria for Stages 2-3 of meaningful use (Lecture b) Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b

  3. Criteria for Stage 1 Meaningful Use (MU) (Blumenthal, 2010; CSC, 2010) • Final rules specified • Core objectives – all must be met • Menu objectives – selected from set • EPs must report on 15 core and 5 of 10 menu objectives • EHs must report on 14 core and 5 of 10 menu objectives • For EPs and EHs, one menu objective must be a public health measure Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 3

  4. Stage 1 Core Objectives • >50% of all unique patients have demographics recorded: preferred language, gender, race, ethnicity, date of birth • >50% of all unique patients age 2+ have recorded height, weight, blood pressure, calculated BMI, growth charts age 2-20 • >80% of all unique patients have at least 1 entry or indication of none on problem list • >80% of all unique patients have at least 1 entry or indication of none on med list Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 4

  5. Stage 1 Core Objectives (continued) • >80% of all unique patients have at least 1 entry or indication of none on med allergy list • >50% of patients age 13+ seen have smoking status recorded • Provide clinical summaries to patient for more than 50% of all office visits within 3 business days Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 5

  6. Stage 1 Core Objectives (continued) • >50% provide patients with an electronic copy of health info upon request within 3 business days • >40% of all permissible prescriptions transmitted electronically (eRx) • >30% of unique patients have at least 1 med order entered using CPOE Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 6

  7. Stage 1 Core Objectives (continued) • Drug-drug and drug-allergy interaction checks enabled • Perform at least 1 test of certified EHR technology's capacity to electronically exchange key clinical information • Implement 1 clinical decision support rule relevant to specialty or high clinical priority with ability to track compliance • Conduct or review a security risk analysis and implement security updates as necessary • Report quality measures to CMS or states – provide aggregate numerator, denominator, and exclusions Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 7

  8. Stage 1 Menu Objectives • Implement drug-formulary checks • >40% results incorporate clinical lab-test results in certified EHR technology as structured data • Generate lists of patients by specific conditions to use for QI, reduction of disparities, research or outreach • >10% use certified EHR technology to identify patient-specific education resources and provide those resources to the patient if appropriate Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 8

  9. Stage 1 Menu Objectives (continued) • Perform medication reconciliation for >50% of transitions of care • Summary of care record is provided for >50% of patient transitions or referrals • Capability to submit electronic data to immunization registries or immunization information systems • Capability to submit electronic syndromic surveillance data to public health agencies Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 9

  10. Stage 1 Menu Objectives for Hospitals Only • >50% of patients age 65+ have an indication of an advance directive status recorded • Perform at least one test of data submission and follow-up submission (where public health agencies can accept electronic data) Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 10

  11. Stage 1 Menu Objectives for Professionals Only • >20% of patients of age 65+ or <5 are sent appropriate reminders for preventive and follow-up care • Provide patients with timely electronic access to their health information – >10% within 4 business days Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 11

  12. Required Standards for Stage 1 • Patient summary – CCR or CCD • ePrescribing – NCPDP/SCRIPT 8.1 or 10.6 • Public health labs, surveillance, and immunizations – HL7 2.3.1 or 2.5.1, CVX • Problem list – SNOMED or ICD-9-CM • Procedures – CPT-4 • Labs – LOINC • Medications – any source in RxNorm • Race/ethnicity – OMB standards Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 12

  13. Required Privacy/Security for Stage 1 • Encryption/decryption • Any approved algorithm in FIPS 140-2 • HIE requires encryption and integrity-protected link • Record actions • Date, time, patient, and user recorded for creation, modification, access, and deletion • Verification of no alteration in transit • SHA-1 algorithm or stronger, as specified in FIPS 180-3 • Record TPO disclosures • Date, time, patient, and user recorded for HIPAA-allowed activities Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 13

  14. Clinical Quality Measures • EPs must report on • 3 core measures • Can substitute alternate core measures if denominator of any core measure is 0 • 3 of 38 additional measures • EHs must report on 15 measures • Reporting by attestation in 2011 and provision of data in 2012 and beyond • CMS aims to align all quality reporting programs, i.e., PQRI, CHIPRA, RHQDAPU, etc. Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 14

  15. Core EP Quality Measures • Hypertension – blood pressure measurement • Tobacco use assessment and cessation intervention • Adult weight screening and follow up Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 15

  16. Alternative EP Quality Measures • Weight assessment and counseling for children and adolescents • Influenza immunization for patients 50+ years • Childhood immunization status Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 16

  17. EP Additional Quality Measures(1-12 out of 38) • Anti-depressant medication management: (a) Effective Acute Phase Treatment, (b)Effective Continuation Phase Treatment • Appropriate Testing for Children with Pharyngitis • Asthma Assessment • Asthma Pharmacologic Therapy • Breast Cancer Screening • Cervical Cancer Screening • Chlamydia Screening for Women • Colorectal Cancer Screening • Controlling High Blood Pressure • Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) • Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol • Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 17

  18. EP Additional Quality Measures(13-24) • Diabetes: Blood Pressure Management • Diabetes: Eye Exam • Diabetes: Foot Exam • Diabetes: Hemoglobin A1c Control (<8.0%) • Diabetes: Hemoglobin A1c Poor Control • Diabetes: Low Density Lipoprotein (LDL) Management and Control • Diabetes: Urine Screening • Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care • Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy • Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) • Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) • Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 18

  19. EP Additional Quality Measures(25-38) • Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: a) Initiation, b) Engagement • Ischemic Vascular Disease (IVD): Blood Pressure Management • Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control • Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic • Low Back Pain: Use of Imaging Studies • Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer • Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients • Pneumonia Vaccination Status for Older Adults • Prenatal Care: Anti-D Immune Globulin • Prenatal Care: Screening for Human Immunodeficiency Virus (HIV) • Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation • Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients • Smoking and Tobacco Use Cessation, Medical Assistance: a) Advising Smokers and Tobacco Users to Quit, b) Discussing Smoking and Tobacco Use Cessation Medications, c) Discussing Smoking and Tobacco Use Cessation Strategies • Use of Appropriate Medications for Asthma Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 19

  20. EH Quality Measures • Anticoagulation overlap therapy • Emergency Department Throughput – admitted patients – Admission decision time to ED departure time for admitted patients • Emergency Department Throughput – admitted patients – Median time from ED arrival to ED departure for admitted patients • Incidence of potentially preventable venous thromboembolism • Intensive Care Unit venous thromboembolism prophylaxis • Ischemic or hemorrhagic stroke – Antithrombotic therapy by day 2 • Ischemic or hemorrhagic stroke – Rehabilitation assessment • Ischemic or hemorrhagic stroke – Stroke education • Ischemic stroke – Anticoagulation for atrial fibrillation/flutter • Ischemic stroke – Discharge on anti-thrombotics • Ischemic stroke – Discharge on statins • Ischemic stroke – Thrombolytic therapy for patients arriving within 2 hours of symptom onset • Platelet monitoring on unfractionated heparin • Venous thromboembolism discharge instructions • Venous thromboembolism prophylaxis within 24 hours of arrival Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 20

  21. How Much is All of This Going To Cost? • CMS estimates of EPs and EHs • 477,500 eligible as Medicare EP • 95,500 of these eligible as Medicaid EP • 44,100 eligible as Medicaid-only EP • 5,011 EHs • 3,620 acute care • 1,302 CAH • 78 children’s • 11 cancer • Estimated achievement of MU in ten years • Low – 95.6% of EHs and 36% of EPs • High – 100% of EHs and 70% of EPs • Total cost: $9.7B (low) to $27.4B (high) Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 21

  22. Beyond Stage 1 • Much speculation around what rules will be for Stage 2 (and Stage 3) • Another challenge is wide variety of other requirements healthcare organizations must undertake in next few years, such as 5010 standards for transactions, ICD-10 coding, and healthcare reform • ONC HIT Policy Committee submitted recommendations in four basic categories for changes in measures from Stage 1 to Stage 2 (Drazen, 2011) • Measures unchanged • Unchanged menu measures become core • Increased threshold or wider scope – e.g., increased proportion of CPOE, decision support rules, etc. • New measures – including focus on usability (Classen, 2011) and/or patient experience (Ralston, 2010) Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 22

  23. Meaningful Use of Health Information Technology Summary – Lecture b • Meaningful use of HIT in the context of the HITECH Act • Core objectives of Stage 1 Meaningful Use • Preview of Stages 2 and 3 Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 23

  24. Meaningful Use of Health Information Technology Summary • Meaningful use program of HITECH • Eligibility for incentive payments • Criteria for achieving those payments in Stage 1 • Standards for Stage 1 of meaningful use, including those devoted to privacy and security • Overview of what might be expected in Stages 2 and 3 Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 24

  25. Meaningful Use of Health Information Technology References – Lecture b References Blumenthal, D., & Tavenner, M. (2010). The “meaningful use” regulation for electronic health records. New England Journal of Medicine, 363, 501-504. Classen, D., & Drazen, E. (2010). Update on Meaningful Use - Final Rules. Waltham, MA: Computer Sciences Corp. Retrieved from http://www.csc.com/health_services/insights/28577-update_on_meaningful_use_the_final_rule. Classen, D., & Bates, D. (2011). Finding the meaning in meaningful use. New England Journal of Medicine, 365, 855-858. Drazen, E. (2011). Update on Stage 2: Current Direction and Timing of Meaningful Use Requirements. Waltham, MA: Computer Sciences Corp. Retrieved from http://www.csc.com/health_services/insights/67921-update_on_stage_2_current_direction_and_timing_of_meaningful_use_requirements Ralston, J., Coleman, K., Reid, R., Handley, M., & Larson, E. (2010). Patient experience should be part of meaningful-use criteria. Health Affairs, 29, 607-613. Introduction to Healthcare and Public Health in the US Meaningful Use of Health Information Technology Lecture b Health IT Workforce Curriculum Version 3.0/Spring 2012 25

More Related